Hello and welcome to the details of Indonesia recommends Sinovac vaccine for children aged 12-17 and now with the details
JAKARTA, June 28 — Indonesia’s food and drug agency has recommended the Covid-19 vaccine made by China’s Sinovac Biotech for children aged 12-17, the country’s Covid-19 task force said, as the country seeks to extend inoculations amid a surge in infections.
Indonesia has reported record daily rises in cases of more than 20,000 recently after the emergence of virus variants and travel after the Muslim fasting month has helped drive a new wave of infections.
Task force spokesman Wiku Adisasmito welcomed the food and drug agency’s (BPOM) recommendation and said “the government invites the people to still wait for the issuance of emergency use approval from BPOM.”
Penny K. Lukito, the head of BPOM, did not immediately respond to a request for comment on the timing of such a ruling.
Indonesia has been using Sinovac as the main plank for its vaccination programme after receiving about 94 million doses, while it has received about 10 million made by AstraZeneca and Sinopharm.
Task force data shows children aged 0-18 account for 12.6 per cent of Indonesia’s total Covid-19 infections.
The World Health Organisation (WHO) approved emergency use of Sinovac’s vaccine this month, saying results showed it prevented symptomatic disease in 51 per cent of recipients and prevented severe Covid-19 and hospital stays.
The Southeast Asian country is under pressure to speed up vaccinations with hospitals in several designated “red zone” reporting overcapacity and with 93 per cent of isolation beds in Jakarta occupied as of yesterday.
Indonesia reported it had given 1.3 million vaccine shots on Saturday, the highest daily count since the programme began in January. About 13.18 million people have received both shots as of today, government data showed. — Reuters
These were the details of the news Indonesia recommends Sinovac vaccine for children aged 12-17 for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.